APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-aging and Longevity Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Anti-aging and Longevity Drugs Industry Research Report 2026

28 December 2025131 pages

Choose your research edition.

Industry ResearchAnti-aging and Longevity Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-aging and Longevity Drugs Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Anti-aging and Longevity Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-aging and Longevity Drugs Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-aging and Longevity Drugs Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Anti-aging and Longevity Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Anti-aging and Longevity Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Anti-aging and Longevity Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Anti-aging and Longevity Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Anti-aging and Longevity Drugs include Centrum, GNC, Herbalmax, HUM Nutrition, MegaFood, Natrol, Nature Made, Nature's Bounty and New Chapter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Anti-aging and Longevity Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Anti-aging and Longevity Drugs Market by Company

Centrum

GNC

Herbalmax

HUM Nutrition

MegaFood

Natrol

Nature Made

Nature's Bounty

New Chapter

Pure Encapsulations

The Vitamin Shoppe

China Resources Double-Crane Pharmaceutical Co.,Ltd.

GeneHarbor (Hong Kong) Biotechnologies Limited

Xiamen Kingdomway Group Company

Shinkowa

Yaben Chemical

Guangdong Zhongsheng Pharmaceutical Co.,Ltd.

Anti-aging and Longevity Drugs Segment by Type

Resveratrol

Coenzyme Q10 and Collagen

Biotin

Vitamins

Nicotinamide Mononucleotide (NMN)

Others

Anti-aging and Longevity Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospitals

Clinics

Anti-aging and Longevity Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-aging and Longevity Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-aging and Longevity Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-aging and Longevity Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Anti-aging and Longevity Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Anti-aging and Longevity Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Anti-aging and Longevity Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Anti-aging and Longevity Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Anti-aging and Longevity Drugs Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Anti-aging and Longevity Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Anti-aging and Longevity Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Anti-aging and Longevity Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Anti-aging and Longevity Drugs Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Anti-aging and Longevity Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Anti-aging and Longevity Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Anti-aging and Longevity Drugs, Product Type & Application Table 14. Global Anti-aging and Longevity Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Anti-aging and Longevity Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Centrum Company Information Table 19. Centrum Business Overview Table 20. Centrum Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Centrum Anti-aging and Longevity Drugs Product Portfolio Table 22. Centrum Recent Developments Table 23. GNC Company Information Table 24. GNC Business Overview Table 25. GNC Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. GNC Anti-aging and Longevity Drugs Product Portfolio Table 27. GNC Recent Developments Table 28. Herbalmax Company Information Table 29. Herbalmax Business Overview Table 30. Herbalmax Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Herbalmax Anti-aging and Longevity Drugs Product Portfolio Table 32. Herbalmax Recent Developments Table 33. HUM Nutrition Company Information Table 34. HUM Nutrition Business Overview Table 35. HUM Nutrition Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. HUM Nutrition Anti-aging and Longevity Drugs Product Portfolio Table 37. HUM Nutrition Recent Developments Table 38. MegaFood Company Information Table 39. MegaFood Business Overview Table 40. MegaFood Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. MegaFood Anti-aging and Longevity Drugs Product Portfolio Table 42. MegaFood Recent Developments Table 43. Natrol Company Information Table 44. Natrol Business Overview Table 45. Natrol Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Natrol Anti-aging and Longevity Drugs Product Portfolio Table 47. Natrol Recent Developments Table 48. Nature Made Company Information Table 49. Nature Made Business Overview Table 50. Nature Made Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Nature Made Anti-aging and Longevity Drugs Product Portfolio Table 52. Nature Made Recent Developments Table 53. Nature's Bounty Company Information Table 54. Nature's Bounty Business Overview Table 55. Nature's Bounty Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Nature's Bounty Anti-aging and Longevity Drugs Product Portfolio Table 57. Nature's Bounty Recent Developments Table 58. New Chapter Company Information Table 59. New Chapter Business Overview Table 60. New Chapter Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. New Chapter Anti-aging and Longevity Drugs Product Portfolio Table 62. New Chapter Recent Developments Table 63. Pure Encapsulations Company Information Table 64. Pure Encapsulations Business Overview Table 65. Pure Encapsulations Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Pure Encapsulations Anti-aging and Longevity Drugs Product Portfolio Table 67. Pure Encapsulations Recent Developments Table 68. The Vitamin Shoppe Company Information Table 69. The Vitamin Shoppe Business Overview Table 70. The Vitamin Shoppe Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. The Vitamin Shoppe Anti-aging and Longevity Drugs Product Portfolio Table 72. The Vitamin Shoppe Recent Developments Table 73. China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Information Table 74. China Resources Double-Crane Pharmaceutical Co.,Ltd. Business Overview Table 75. China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio Table 77. China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Developments Table 78. GeneHarbor (Hong Kong) Biotechnologies Limited Company Information Table 79. GeneHarbor (Hong Kong) Biotechnologies Limited Business Overview Table 80. GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Product Portfolio Table 82. GeneHarbor (Hong Kong) Biotechnologies Limited Recent Developments Table 83. Xiamen Kingdomway Group Company Company Information Table 84. Xiamen Kingdomway Group Company Business Overview Table 85. Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Product Portfolio Table 87. Xiamen Kingdomway Group Company Recent Developments Table 88. Shinkowa Company Information Table 89. Shinkowa Business Overview Table 90. Shinkowa Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Shinkowa Anti-aging and Longevity Drugs Product Portfolio Table 92. Shinkowa Recent Developments Table 93. Yaben Chemical Company Information Table 94. Yaben Chemical Business Overview Table 95. Yaben Chemical Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Yaben Chemical Anti-aging and Longevity Drugs Product Portfolio Table 97. Yaben Chemical Recent Developments Table 98. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Information Table 99. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Business Overview Table 100. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio Table 102. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Recent Developments Table 103. Global Anti-aging and Longevity Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Anti-aging and Longevity Drugs Sales by Region (2021-2026) & (K Units) Table 105. Global Anti-aging and Longevity Drugs Sales Market Share by Region (2021-2026) Table 106. Global Anti-aging and Longevity Drugs Sales by Region (2027-2032) & (K Units) Table 107. Global Anti-aging and Longevity Drugs Sales Market Share by Region (2027-2032) Table 108. Global Anti-aging and Longevity Drugs Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Anti-aging and Longevity Drugs Revenue Market Share by Region (2021-2026) Table 110. Global Anti-aging and Longevity Drugs Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Anti-aging and Longevity Drugs Revenue Market Share by Region (2027-2032) Table 112. North America Anti-aging and Longevity Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units) Table 114. North America Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units) Table 115. North America Anti-aging and Longevity Drugs Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Anti-aging and Longevity Drugs Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Anti-aging and Longevity Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units) Table 119. Europe Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units) Table 120. Europe Anti-aging and Longevity Drugs Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Anti-aging and Longevity Drugs Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Anti-aging and Longevity Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Anti-aging and Longevity Drugs Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Anti-aging and Longevity Drugs Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Anti-aging and Longevity Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units) Table 129. South America Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units) Table 130. South America Anti-aging and Longevity Drugs Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Anti-aging and Longevity Drugs Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Anti-aging and Longevity Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Anti-aging and Longevity Drugs Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Anti-aging and Longevity Drugs Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Anti-aging and Longevity Drugs Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Anti-aging and Longevity Drugs Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Anti-aging and Longevity Drugs Sales by Type (2021-2026) & (K Units) Table 138. Global Anti-aging and Longevity Drugs Sales by Type (2027-2032) & (K Units) Table 139. Global Anti-aging and Longevity Drugs Sales Market Share by Type (2021-2026) Table 140. Global Anti-aging and Longevity Drugs Sales Market Share by Type (2027-2032) Table 141. Global Anti-aging and Longevity Drugs Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Anti-aging and Longevity Drugs Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2021-2026) Table 144. Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2027-2032) Table 145. Global Anti-aging and Longevity Drugs Price by Type (2021-2026) & (US$/Unit) Table 146. Global Anti-aging and Longevity Drugs Price by Type (2027-2032) & (US$/Unit) Table 147. Global Anti-aging and Longevity Drugs Sales by Application (2021-2026) & (K Units) Table 148. Global Anti-aging and Longevity Drugs Sales by Application (2027-2032) & (K Units) Table 149. Global Anti-aging and Longevity Drugs Sales Market Share by Application (2021-2026) Table 150. Global Anti-aging and Longevity Drugs Sales Market Share by Application (2027-2032) Table 151. Global Anti-aging and Longevity Drugs Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Anti-aging and Longevity Drugs Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2021-2026) Table 154. Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2027-2032) Table 155. Global Anti-aging and Longevity Drugs Price by Application (2021-2026) & (US$/Unit) Table 156. Global Anti-aging and Longevity Drugs Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Anti-aging and Longevity Drugs Distributors List Table 160. Anti-aging and Longevity Drugs Customers List Table 161. Anti-aging and Longevity Drugs Industry Trends Table 162. Anti-aging and Longevity Drugs Industry Drivers Table 163. Anti-aging and Longevity Drugs Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Anti-aging and Longevity Drugs Product Image Figure 5. Global Anti-aging and Longevity Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Anti-aging and Longevity Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Anti-aging and Longevity Drugs Sales (2021-2032) & (K Units) Figure 8. Global Anti-aging and Longevity Drugs Average Price (US$/Unit) & (2021-2032) Figure 9. Resveratrol Product Image Figure 10. Coenzyme Q10 and Collagen Product Image Figure 11. Biotin Product Image Figure 12. Vitamins Product Image Figure 13. Nicotinamide Mononucleotide (NMN) Product Image Figure 14. Others Product Image Figure 15. Retail Pharmacies Product Image Figure 16. Online Pharmacies Product Image Figure 17. Hospitals Product Image Figure 18. Clinics Product Image Figure 19. Global Anti-aging and Longevity Drugs Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Anti-aging and Longevity Drugs, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Anti-aging and Longevity Drugs Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Anti-aging and Longevity Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Anti-aging and Longevity Drugs Sales by Region in 2025 Figure 25. Global Anti-aging and Longevity Drugs Revenue by Region in 2025 Figure 26. North America Anti-aging and Longevity Drugs Market Size by Country in 2025 Figure 27. North America Anti-aging and Longevity Drugs Sales Market Share by Country (2021-2032) Figure 28. North America Anti-aging and Longevity Drugs Revenue Market Share by Country (2021-2032) Figure 29. United States Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Mexico Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Europe Anti-aging and Longevity Drugs Market Size by Country in 2025 Figure 33. Europe Anti-aging and Longevity Drugs Sales Market Share by Country (2021-2032) Figure 34. Europe Anti-aging and Longevity Drugs Revenue Market Share by Country (2021-2032) Figure 35. Germany Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. France Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. U.K. Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Italy Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Russia Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Spain Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Netherlands Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Switzerland Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Sweden Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Poland Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Asia Pacific Anti-aging and Longevity Drugs Market Size by Country in 2025 Figure 46. Asia Pacific Anti-aging and Longevity Drugs Sales Market Share by Country (2021-2032) Figure 47. Asia Pacific Anti-aging and Longevity Drugs Revenue Market Share by Country (2021-2032) Figure 48. China Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Japan Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South Korea Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. India Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Australia Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Taiwan Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. South America Anti-aging and Longevity Drugs Market Size by Country in 2025 Figure 57. South America Anti-aging and Longevity Drugs Sales Market Share by Country (2021-2032) Figure 58. South America Anti-aging and Longevity Drugs Revenue Market Share by Country (2021-2032) Figure 59. Brazil Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Argentina Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Chile Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Colombia Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Middle East and Africa Anti-aging and Longevity Drugs Market Size by Country in 2025 Figure 64. Middle East and Africa Anti-aging and Longevity Drugs Sales Market Share by Country (2021-2032) Figure 65. Middle East and Africa Anti-aging and Longevity Drugs Revenue Market Share by Country (2021-2032) Figure 66. Egypt Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. South Africa Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Israel Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Türkiye Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. GCC Countries Anti-aging and Longevity Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. Global Anti-aging and Longevity Drugs Sales Market Share by Type (2021-2032) Figure 72. Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2021-2032) Figure 73. Global Anti-aging and Longevity Drugs Price (US$/Unit) by Type (2021-2032) Figure 74. Global Anti-aging and Longevity Drugs Sales Market Share by Application (2021-2032) Figure 75. Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2021-2032) Figure 76. Global Anti-aging and Longevity Drugs Price (US$/Unit) by Application (2021-2032) Figure 77. Anti-aging and Longevity Drugs Value Chain Figure 78. Anti-aging and Longevity Drugs Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Anti-aging and Longevity Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Resveratrol
  • Coenzyme Q10 and Collagen
  • Biotin
  • Vitamins
  • Nicotinamide Mononucleotide (NMN)
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospitals
  • Clinics
Companies covered
  • Centrum
  • GNC
  • Herbalmax
  • HUM Nutrition
  • MegaFood
  • Natrol
  • Nature Made
  • Nature's Bounty
  • New Chapter
  • Pure Encapsulations
  • The Vitamin Shoppe
  • China Resources Double-Crane Pharmaceutical Co.,Ltd.
  • GeneHarbor (Hong Kong) Biotechnologies Limited
  • Xiamen Kingdomway Group Company
  • Shinkowa
  • Yaben Chemical
  • Guangdong Zhongsheng Pharmaceutical Co.,Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Anti-aging and Longevity Drugs Market Size (2021-2032)
  4. 2.2.2 Global Anti-aging and Longevity Drugs Sales (2021-2032)
  5. 2.2.3 Global Anti-aging and Longevity Drugs Market Average Price (2021-2032)
  6. 2.3 Anti-aging and Longevity Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Resveratrol
  9. 2.3.3 Coenzyme Q10 and Collagen
  10. 2.3.4 Biotin
  11. 2.3.5 Vitamins
  12. 2.3.6 Nicotinamide Mononucleotide (NMN)
  13. 2.3.7 Others
  14. 2.4 Anti-aging and Longevity Drugs by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Retail Pharmacies
  17. 2.4.3 Online Pharmacies
  18. 2.4.4 Hospitals
  19. 2.4.5 Clinics
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Anti-aging and Longevity Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Anti-aging and Longevity Drugs Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Anti-aging and Longevity Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Anti-aging and Longevity Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Anti-aging and Longevity Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Anti-aging and Longevity Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Anti-aging and Longevity Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Anti-aging and Longevity Drugs, Established Date
  9. 3.9 Global Anti-aging and Longevity Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Centrum
  2. 4.1.1 Centrum Company Information
  3. 4.1.2 Centrum Business Overview
  4. 4.1.3 Centrum Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Centrum Anti-aging and Longevity Drugs Product Portfolio
  6. 4.1.5 Centrum Recent Developments
  7. 4.2 GNC
  8. 4.2.1 GNC Company Information
  9. 4.2.2 GNC Business Overview
  10. 4.2.3 GNC Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 GNC Anti-aging and Longevity Drugs Product Portfolio
  12. 4.2.5 GNC Recent Developments
  13. 4.3 Herbalmax
  14. 4.3.1 Herbalmax Company Information
  15. 4.3.2 Herbalmax Business Overview
  16. 4.3.3 Herbalmax Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Herbalmax Anti-aging and Longevity Drugs Product Portfolio
  18. 4.3.5 Herbalmax Recent Developments
  19. 4.4 HUM Nutrition
  20. 4.4.1 HUM Nutrition Company Information
  21. 4.4.2 HUM Nutrition Business Overview
  22. 4.4.3 HUM Nutrition Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 HUM Nutrition Anti-aging and Longevity Drugs Product Portfolio
  24. 4.4.5 HUM Nutrition Recent Developments
  25. 4.5 MegaFood
  26. 4.5.1 MegaFood Company Information
  27. 4.5.2 MegaFood Business Overview
  28. 4.5.3 MegaFood Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 MegaFood Anti-aging and Longevity Drugs Product Portfolio
  30. 4.5.5 MegaFood Recent Developments
  31. 4.6 Natrol
  32. 4.6.1 Natrol Company Information
  33. 4.6.2 Natrol Business Overview
  34. 4.6.3 Natrol Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Natrol Anti-aging and Longevity Drugs Product Portfolio
  36. 4.6.5 Natrol Recent Developments
  37. 4.7 Nature Made
  38. 4.7.1 Nature Made Company Information
  39. 4.7.2 Nature Made Business Overview
  40. 4.7.3 Nature Made Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Nature Made Anti-aging and Longevity Drugs Product Portfolio
  42. 4.7.5 Nature Made Recent Developments
  43. 4.8 Nature's Bounty
  44. 4.8.1 Nature's Bounty Company Information
  45. 4.8.2 Nature's Bounty Business Overview
  46. 4.8.3 Nature's Bounty Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Nature's Bounty Anti-aging and Longevity Drugs Product Portfolio
  48. 4.8.5 Nature's Bounty Recent Developments
  49. 4.9 New Chapter
  50. 4.9.1 New Chapter Company Information
  51. 4.9.2 New Chapter Business Overview
  52. 4.9.3 New Chapter Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 New Chapter Anti-aging and Longevity Drugs Product Portfolio
  54. 4.9.5 New Chapter Recent Developments
  55. 4.10 Pure Encapsulations
  56. 4.10.1 Pure Encapsulations Company Information
  57. 4.10.2 Pure Encapsulations Business Overview
  58. 4.10.3 Pure Encapsulations Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Pure Encapsulations Anti-aging and Longevity Drugs Product Portfolio
  60. 4.10.5 Pure Encapsulations Recent Developments
  61. 4.11 The Vitamin Shoppe
  62. 4.11.1 The Vitamin Shoppe Company Information
  63. 4.11.2 The Vitamin Shoppe Business Overview
  64. 4.11.3 The Vitamin Shoppe Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 The Vitamin Shoppe Anti-aging and Longevity Drugs Product Portfolio
  66. 4.11.5 The Vitamin Shoppe Recent Developments
  67. 4.12 China Resources Double-Crane Pharmaceutical Co.,Ltd.
  68. 4.12.1 China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Information
  69. 4.12.2 China Resources Double-Crane Pharmaceutical Co.,Ltd. Business Overview
  70. 4.12.3 China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
  72. 4.12.5 China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Developments
  73. 4.13 GeneHarbor (Hong Kong) Biotechnologies Limited
  74. 4.13.1 GeneHarbor (Hong Kong) Biotechnologies Limited Company Information
  75. 4.13.2 GeneHarbor (Hong Kong) Biotechnologies Limited Business Overview
  76. 4.13.3 GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Product Portfolio
  78. 4.13.5 GeneHarbor (Hong Kong) Biotechnologies Limited Recent Developments
  79. 4.14 Xiamen Kingdomway Group Company
  80. 4.14.1 Xiamen Kingdomway Group Company Company Information
  81. 4.14.2 Xiamen Kingdomway Group Company Business Overview
  82. 4.14.3 Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Product Portfolio
  84. 4.14.5 Xiamen Kingdomway Group Company Recent Developments
  85. 4.15 Shinkowa
  86. 4.15.1 Shinkowa Company Information
  87. 4.15.2 Shinkowa Business Overview
  88. 4.15.3 Shinkowa Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Shinkowa Anti-aging and Longevity Drugs Product Portfolio
  90. 4.15.5 Shinkowa Recent Developments
  91. 4.16 Yaben Chemical
  92. 4.16.1 Yaben Chemical Company Information
  93. 4.16.2 Yaben Chemical Business Overview
  94. 4.16.3 Yaben Chemical Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Yaben Chemical Anti-aging and Longevity Drugs Product Portfolio
  96. 4.16.5 Yaben Chemical Recent Developments
  97. 4.17 Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
  98. 4.17.1 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Information
  99. 4.17.2 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Business Overview
  100. 4.17.3 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
  102. 4.17.5 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Recent Developments
5 Global Anti-aging and Longevity Drugs Market Scenario by Region
  1. 5.1 Global Anti-aging and Longevity Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Anti-aging and Longevity Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Anti-aging and Longevity Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Anti-aging and Longevity Drugs Sales by Region: 2027-2032
  5. 5.3 Global Anti-aging and Longevity Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Anti-aging and Longevity Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Anti-aging and Longevity Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Anti-aging and Longevity Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Anti-aging and Longevity Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Anti-aging and Longevity Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Anti-aging and Longevity Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Anti-aging and Longevity Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Anti-aging and Longevity Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Anti-aging and Longevity Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Anti-aging and Longevity Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Anti-aging and Longevity Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Anti-aging and Longevity Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Anti-aging and Longevity Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Anti-aging and Longevity Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Anti-aging and Longevity Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Anti-aging and Longevity Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Anti-aging and Longevity Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Anti-aging and Longevity Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Anti-aging and Longevity Drugs Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Anti-aging and Longevity Drugs Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Anti-aging and Longevity Drugs Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Anti-aging and Longevity Drugs Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Anti-aging and Longevity Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Anti-aging and Longevity Drugs Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Anti-aging and Longevity Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Anti-aging and Longevity Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Anti-aging and Longevity Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Anti-aging and Longevity Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Anti-aging and Longevity Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Anti-aging and Longevity Drugs Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Anti-aging and Longevity Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Anti-aging and Longevity Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Anti-aging and Longevity Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Anti-aging and Longevity Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Anti-aging and Longevity Drugs Value Chain Analysis
  2. 8.1.1 Anti-aging and Longevity Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Anti-aging and Longevity Drugs Production Mode & Process
  5. 8.2 Anti-aging and Longevity Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Anti-aging and Longevity Drugs Distributors
  8. 8.2.3 Anti-aging and Longevity Drugs Customers
9 Global Anti-aging and Longevity Drugs Analyzing Market Dynamics
  1. 9.1 Anti-aging and Longevity Drugs Industry Trends
  2. 9.2 Anti-aging and Longevity Drugs Industry Drivers
  3. 9.3 Anti-aging and Longevity Drugs Industry Opportunities and Challenges
  4. 9.4 Anti-aging and Longevity Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst